Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Evaluation of Immune Effector Cell-Associated Neurotoxicity Syndrome Associated With Bispecific Antibodies in Real-World Clinical Use: A Pharmacovigilance Study (2023-2026)

ABCL - 1052

Evaluation of Immune Effector Cell-Associated Neurotoxicity Syndrome Associated With Bispecific Antibodies in Real-World Clinical Use: A Pharmacovigilance Study (2023-2026)

Ashleigh Herbert

Poster Presenter: Ashleigh Herbert

Thumbnail for Design Verification Testing of a Highly Sensitive Multiplex qPCR Assay That Detects the JAK2 V617F Variant Commonly Present in Myeloproliferative Neoplasms

MPN - 1053

Design Verification Testing of a Highly Sensitive Multiplex qPCR Assay That Detects the JAK2 V617F Variant Commonly Present in Myeloproliferative Neoplasms

Jonathan Turner

Poster Presenter: Jonathan Turner

Previous 1...84 85 86 87 88 89 90...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Stem Cell Support as a Salvage Therapy for Prolonged Severe Hematologic Toxicity Following CAR-T Therapy

CT - 1056

Stem Cell Support as a Salvage Therapy for Prolonged Severe Hematologic Toxicity Following CAR-T Therapy

ZhuoXin Zhang

Poster Presenter: ZhuoXin Zhang

Thumbnail for Comparative Efficacy and Safety of Next-Generation JAK Inhibitors (Fedratinib, Pacritinib, and Momelotinib) in Myelofibrosis: A Systematic Review and Meta-Analysis

MPN - 1057

Comparative Efficacy and Safety of Next-Generation JAK Inhibitors (Fedratinib, Pacritinib, and Momelotinib) in Myelofibrosis: A Systematic Review and Meta-Analysis

Ajina Joy

Poster Presenter: Ajina Joy

Thumbnail for Phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical activity of the antibody-drug conjugate (ADC) ARC-02 as monotherapy and in combination with rituximab in adults with B-cell non-Hodgkins lymphoma (NHL)

ABCL - 1058

Phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical activity of the antibody-drug conjugate (ADC) ARC-02 as monotherapy and in combination with rituximab in adults with B-cell non-Hodgkins lymphoma (NHL)

Sinya Okamura

Poster Presenter: Sinya Okamura

$Thumbnail for Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis$

CLL - 1061

Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis

Subodh Mathew

Poster Presenter: Subodh Mathew

$Thumbnail for Artificial Intelligence, Machine Learning, and Radiomics-Based Prediction Models in Relapsed or Refractory Hodgkin Lymphoma: A Systematic Review$

HL - 1062

Artificial Intelligence, Machine Learning, and Radiomics-Based Prediction Models in Relapsed or Refractory Hodgkin Lymphoma: A Systematic Review

Sai Harsha Yendluri

Poster Presenter: Sai Harsha Yendluri

Thumbnail for Temporal Trends and Demographic Disparities in Hematologic Malignancy Mortality in the United States

CLL - 1063

Temporal Trends and Demographic Disparities in Hematologic Malignancy Mortality in the United States

Baqir Jafry

Poster Presenter: Baqir Jafry

Thumbnail for Circulating Tumor DNA and PCR-Based Minimal Residual Disease for Predicting Outcomes in Follicular Lymphoma After Immunochemotherapy: A Systematic Review and Meta-Analysis.

IBCL - 1065

Circulating Tumor DNA and PCR-Based Minimal Residual Disease for Predicting Outcomes in Follicular Lymphoma After Immunochemotherapy: A Systematic Review and Meta-Analysis.

Kesar Prajapati

Poster Presenter: Kesar Prajapati

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors